Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Brad Tade
Brad Tade is recorded as CFO at Adma Biologics, Inc. (ADMA). Adma Biologics, Inc. reported in an 8-K filed February 25, 2026 that Brad Tade retired as Chief Financial Officer and Treasurer. Adma Biologics, Inc. reported in an 8-K filed February 25, 2026 that Brad Tade retired as Chief Financial Officer and Treasurer, effective February 25, 2026. Adma Biologics, Inc. reported in an 8-K filed July 26, 2024 that Brad Tade was appointed Chief Financial Officer and Treasurer, effective July 24, 2024. Brad Tade has spoken on 6 earnings calls across 1 company, most recently for Adma Biologics, Inc. on February 25, 2026.
“ADMA announced the retirement of Brad Tade as Chief Financial Officer and Treasurer following a successful tenure that supported the Company's transformation to sustained profitability.”
Adma Biologics, Inc. Form 8-K, filed February 25, 2026
· Read the filing
“On February 20, 2026, Brad Tade notified the Company that he is retiring from his position as Chief Financial Officer and Treasurer of the Company effective at the close of business on February 25, 2026, following the filing of the Company's Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K").”
Adma Biologics, Inc. Form 8-K, filed February 25, 2026
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
